发布求助
文献互助 智能选刊 最新文献

Future cardiology最新文献

筛选
英文 中文
Coronary intravascular lithotripsy: the tombstone of coronary calcium. 冠状动脉血管内碎石术：冠状动脉钙化的墓碑。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-10-29 DOI: 10.1080/14796678.2024.2411191
Chandrashekar Bohra, Amit Gulati, Amit Hooda
{"title":"Coronary intravascular lithotripsy: the tombstone of coronary calcium.","authors":"Chandrashekar Bohra, Amit Gulati, Amit Hooda","doi":"10.1080/14796678.2024.2411191","DOIUrl":"10.1080/14796678.2024.2411191","url":null,"abstract":"","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"669-670"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Get pumped for the new year with Future Cardiology: welcome to volume 20. 未来心脏病学》为新的一年注入活力：欢迎阅读第 20 卷。
IF 1.7
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.2217/fca-2023-0130
Ashling Cannon
{"title":"Get pumped for the new year with <i>Future Cardiology</i>: welcome to volume 20.","authors":"Ashling Cannon","doi":"10.2217/fca-2023-0130","DOIUrl":"10.2217/fca-2023-0130","url":null,"abstract":"","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-4"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139466415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy and correlation of bed and standing scale weights in monitoring volume status in heart failure patients. 卧床和站立体重秤在监测心力衰竭患者容量状态方面的准确性和相关性。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-05-06 DOI: 10.1080/14796678.2024.2340919
Devin Skoll, Phillip Abarca, Vu Pham, Anushka Das, Clark Mantini, Han Tun, Helga Van Herle, Ajay Vaidya, Aaron M Wolfson, Michael W Fong
{"title":"Accuracy and correlation of bed and standing scale weights in monitoring volume status in heart failure patients.","authors":"Devin Skoll, Phillip Abarca, Vu Pham, Anushka Das, Clark Mantini, Han Tun, Helga Van Herle, Ajay Vaidya, Aaron M Wolfson, Michael W Fong","doi":"10.1080/14796678.2024.2340919","DOIUrl":"10.1080/14796678.2024.2340919","url":null,"abstract":"<p><p><b>Introduction:</b> Accurate volume status monitoring is crucial for effective diuretic therapy in patients with acute decompensated heart failure (ADHF). While guidelines recommend daily standing body weight measurement as an indicator of volume status, bed scales are commonly used in healthcare facilities.<b>Methods:</b> A method-comparison design was used to compare bed and standing scale weights among adults hospitalized with ADHF at Los Angeles County-University of Southern California Medical Center between March and April 2023.<b>Results & Conclusion:</b> Among 51 weight pairs from 43 participants, a clinically significant mean difference of 1.42 ± 1.18 kg was observed, exceeding the recommended threshold. Inaccuracies, with 71% showing differences >0.6 kg, highlight potential fluid management errors when relying on bed scales in ADHF hospitalizations.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"389-393"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges and advances in device-related thrombus in left atrial appendage occlusion. 左心房阑尾闭塞中与设备相关血栓的挑战和进展。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-07-01 DOI: 10.1080/14796678.2024.2363063
Takamasa Tanaka, Kenji Kawai, Christopher R Ellis, Mukta Srivastava, Rika Kawakami, Takao Konishi, Tatsuya Shiraki, Teruo Sekimoto, Renu Virmani, Aloke V Finn
{"title":"Challenges and advances in device-related thrombus in left atrial appendage occlusion.","authors":"Takamasa Tanaka, Kenji Kawai, Christopher R Ellis, Mukta Srivastava, Rika Kawakami, Takao Konishi, Tatsuya Shiraki, Teruo Sekimoto, Renu Virmani, Aloke V Finn","doi":"10.1080/14796678.2024.2363063","DOIUrl":"10.1080/14796678.2024.2363063","url":null,"abstract":"<p><p>Oral anticoagulation therapy (OAC) is a mainstay for mitigating stroke and other embolic events in patients with atrial fibrillation (AF). Despite the demonstrated efficacy of OAC in reducing events, many patients are unable to tolerate OAC due to bleeding risks. Left atrial appendage occlusion (LAAO) devices were developed as implantable technologies to moderate stroke risk in patients with intolerance to OAC. Despite clinical data supporting near-comparable protection against thromboembolic events with OAC, device-related thrombus formation has emerged as a critical complication following LAAO that remains a potential limitation to the safety and efficacy of LAAO. Improved biocompatibility of LAAO devices with fluoropolymers, a well-established stent-coating technology used to reduce thrombus formation and promote endothelialization, may optimize outcomes after LAAO.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"343-358"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141467457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitral valve replacement in young patients: review and current challenges. 年轻患者的二尖瓣置换术：回顾与当前挑战。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-07-10 DOI: 10.1080/14796678.2024.2343592
Fadi Hage, Ali Hage, Manuel R Cervetti, Michael W A Chu
{"title":"Mitral valve replacement in young patients: review and current challenges.","authors":"Fadi Hage, Ali Hage, Manuel R Cervetti, Michael W A Chu","doi":"10.1080/14796678.2024.2343592","DOIUrl":"10.1080/14796678.2024.2343592","url":null,"abstract":"<p><p>Mitral valve repair is the ideal intervention for mitral valve disease with excellent long-term survival comparable to the age-matched general population. When the mitral valve is not repairable, mechanical prostheses may be associated with improved survival as compared with biological prostheses. Newer mechanical and biological valve prostheses have the potential to improve outcomes following mitral valve replacement in young patients. Patients presenting for mitral valve surgery after failed transcatheter mitral valve-in-valve have high rates of postoperative mortality and morbidity, exceeding those seen with reoperative mitral valve surgery, which poses issues in young patients who have a higher cumulative incidence of reintervention.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"409-417"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ITIH4 is a predictor for coronary thrombus in coronary arteriography patients. ITIH4 是冠状动脉造影患者冠状动脉血栓的预测因子。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-07-23 DOI: 10.1080/14796678.2024.2377924
Lei Tian, Su Zhao, Ruiyan Zhang
{"title":"ITIH4 is a predictor for coronary thrombus in coronary arteriography patients.","authors":"Lei Tian, Su Zhao, Ruiyan Zhang","doi":"10.1080/14796678.2024.2377924","DOIUrl":"10.1080/14796678.2024.2377924","url":null,"abstract":"<p><p><b>Aim:</b> To explore potential value of inter-alpha-trypsin inhibitor heavy chain-4 (ITIH4) for coronary artery disease (CAD) diagnosis.<b>Patients & methods:</b> We recruited the patients who received coronary arteriography (CAG) examination. The enzyme-linked immunosorbent assay was used to detect plasma ITIH4.<b>Results:</b> ITIH4 level was lower expression in CAD patients than that in patients of control group, and was negatively correlated with C-reactive protein (CRP). ITIH4 level is no differences between ST-elevated myocardial infarction (STEMI) and non-ST-elevated myocardial infarction (NSTEMI) patients. However, its expression was significantly correlated with D-Dimer and thrombin time, and the logistic analysis confirmed predictive value of ITIH4 for visible thrombus in coronary.<b>Conclusion:</b> ITIH4 may be a useful biomarker in CAD diagnosis, and to predict visible thrombus in coronary.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"547-554"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of comorbidities and sociodemographic predictors on pneumococcal vaccination coverage in adults with coronary heart disease. 合并症和社会人口学预测因素对冠心病成人肺炎球菌疫苗接种覆盖率的影响。
IF 1.7
Future cardiology Pub Date : 2024-01-01 Epub Date: 2023-12-19 DOI: 10.2217/fca-2023-0095
Saint-Martin Allihien, Sammudeen Ibrahim, Favour Markson, Walter Y Agyeman, Setri Fugar, Onoriode Kesiena
{"title":"The impact of comorbidities and sociodemographic predictors on pneumococcal vaccination coverage in adults with coronary heart disease.","authors":"Saint-Martin Allihien, Sammudeen Ibrahim, Favour Markson, Walter Y Agyeman, Setri Fugar, Onoriode Kesiena","doi":"10.2217/fca-2023-0095","DOIUrl":"10.2217/fca-2023-0095","url":null,"abstract":"<p><p><b>Aim:</b> Coronary heart disease (CHD) increases the risk of adverse outcomes from invasive pneumococcal disease. <b>Methods:</b> Using the 2020 and 2021 data from the national health interview survey, we identified adults with CHD. Chi-square analysis and logistic regression were used to examine factors that influence vaccination status. <b>Results:</b> There were 2675 participants aged 41 and above with CHD. Participants were predominantly white people (82.5%) and males (60.1%). The odds of receiving the pneumococcal vaccine increased with stepwise increase in comorbidities from 1 to 2 and from 2 to 3. Among individuals with ≥2 comorbidities, black people were less likely to be vaccinated compared with white people. <b>Conclusion:</b> Pneumococcal vaccine uptake among adults with CHD is determined by cumulative comorbidities and ethnicity.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"11-19"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138800822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Organizational challenges for partial heart transplantation. 部分心脏移植的组织挑战。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-09-27 DOI: 10.1080/14796678.2024.2404775
Vincent S Alexander, Andrew D Vogel, Zachary T Silvano, Herra Javed, Alekhya Mitta, Taufiek Konrad Rajab
{"title":"Organizational challenges for partial heart transplantation.","authors":"Vincent S Alexander, Andrew D Vogel, Zachary T Silvano, Herra Javed, Alekhya Mitta, Taufiek Konrad Rajab","doi":"10.1080/14796678.2024.2404775","DOIUrl":"10.1080/14796678.2024.2404775","url":null,"abstract":"<p><p>Partial heart transplantation (PHT) has emerged as a new treatment strategy to correct unrepairable heart valve dysfunction in pediatric patients. PHT selectively replaces the dysfunctional components of the recipient's heart and spares the native ventricles. As a result, the transplant biology of PHTs differs from heart transplants. Notably, donor hearts that are unsuitable for whole heart transplantation can be used, graft preservation can be prolonged and immunosuppression levels can be lowered. These nuances of PHT transplant biology have important implications for organizational aspects of PHT clinical application.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"719-728"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new goal for secondary prevention of cardiovascular diseases: the reduction of neutrophil count. 心血管疾病二级预防的新目标：减少中性粒细胞数量。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-08-07 DOI: 10.1080/14796678.2024.2384239
Stefano De Servi, Antonio Landi
{"title":"A new goal for secondary prevention of cardiovascular diseases: the reduction of neutrophil count.","authors":"Stefano De Servi, Antonio Landi","doi":"10.1080/14796678.2024.2384239","DOIUrl":"10.1080/14796678.2024.2384239","url":null,"abstract":"","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"517-519"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methotrexate, blood pressure and arterial function in rheumatoid arthritis: study protocol. 甲氨蝶呤、类风湿性关节炎患者的血压和动脉功能：研究方案。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-10-10 DOI: 10.1080/14796678.2024.2411167
Arduino A Mangoni, Michael D Wiese, Richard J Woodman, Salvatore Sotgia, Angelo Zinellu, Ciriaco Carru, Julie-Ann Hulin, E Michael Shanahan, Sara Tommasi
{"title":"Methotrexate, blood pressure and arterial function in rheumatoid arthritis: study protocol.","authors":"Arduino A Mangoni, Michael D Wiese, Richard J Woodman, Salvatore Sotgia, Angelo Zinellu, Ciriaco Carru, Julie-Ann Hulin, E Michael Shanahan, Sara Tommasi","doi":"10.1080/14796678.2024.2411167","DOIUrl":"10.1080/14796678.2024.2411167","url":null,"abstract":"<p><p>This article discusses the rationale and design of the study \"Methotrexate, blood pressure, and arterial function in rheumatoid arthritis\". The recognition that immune activation and excess inflammation favor atherosclerosis has stimulated a significant body of research not only to identify new drugs targeting these pathways but also to repurpose (reposition) existing immunomodulatory medications as atheroprotective agents. Observational studies in patients with rheumatoid arthritis have reported that treatment with methotrexate, a traditional disease-modifying antirheumatic drug, is associated with a significantly lower risk of cardiovascular morbidity and mortality when compared with other disease-modifying antirheumatic drugs. One potential mechanism accounting for the reduced cardiovascular risk associated with methotrexate is the lowering effect on arterial blood pressure. However, such effect has only been observed in cross-sectional and observational studies. Given the established role of hypertension as a leading cardiovascular risk factor, these observations justify an intervention comparison study, the focus of this article, investigating the temporal effects of methotrexate on blood pressure and various surrogate markers of atherosclerosis in patients with rheumatoid arthritis. The results of this study might lead to the repurposing of methotrexate for cardiovascular prevention in patients with and without autoimmune disorders.<b>Clinical Trial Registration:</b> NCT03254589 (ClinicalTrials.gov).</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"671-683"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信